Essentially, the 2007 drug driving laws made provision for two new offences within the Road Traffic Act 1974: Driving with the presence of a prescribed illicit drug in oral fluid or blood; and Driving while impaired by a drug.
The 2007 drug driving laws also allowed for the introduction of random roadside drug testing, where drivers stopped by police may be required to provide a saliva sample to be tested for drugs. Random drug testing focuses on identifying the presence of a prescribed illicit drug in the salvia or blood of a driver and does not attempt to quantify any level of impairment. Random drug testing is focused on the detection of recent use of prescribed illicit drugs: THC (the active ingredient in cannabis), methylamphetamine (‘speed’ or ‘ice’) and MDMA (‘ecstasy’). The new and revised laws also focus on driver impairment and are concerned with identifying and prosecuting drivers who are visibly impaired by drugs. In the first instance, the impaired driving legislation relies on visual evidence of possible driver impairment by a police officer, followed by standardized assessment procedures. Where drug impairment is suspected, a blood and urine sample is collected. The police report and the blood/urine tests results are then reviewed and, where expert opinion supports the police and toxicological evidence, a drug impaired driving charge will result.New penalties were then introduced as of 1 October 2011.
In the drug driving legislation the term ‘prescribed drugs’ is used. This is a legal term and relates to those drugs prescribed in the regulations. The term should not be confused with prescription medicines that are prescribed by a doctor.
Where the term ‘prescribed drugs’ is used in this document it refers to THC (the active ingredient in cannabis), methylamphetamines (eg ‘speed’ or ‘ice’) and MDMA (eg ‘ecstasy’).
While the legislation uses the term oral fluid where appropriate the more familiar term saliva has been used.